Archives of Physical Medicine and Rehabilitation
Volume 90, Issue 5 , Pages 733-740 , May 2009

A Randomized Controlled Trial of Sertraline for the Treatment of Depression in Persons With Traumatic Brain Injury

  • Teresa A. Ashman, PhD

      Affiliations

    • Department of Rehabilitation Medicine, Mount Sinai School of Medicine, New York, NY
    • Corresponding Author InformationReprint requests to Teresa A. Ashman, PhD, Mount Sinai School of Medicine, Dept of Rehabilitation, One Gustave L Levy Pl, Box 1240, New York, NY 10029
    • ,
  • Joshua B. Cantor, PhD

      Affiliations

    • Department of Rehabilitation Medicine, Mount Sinai School of Medicine, New York, NY
    • ,
  • Wayne A. Gordon, PhD

      Affiliations

    • Department of Rehabilitation Medicine, Mount Sinai School of Medicine, New York, NY
    • ,
  • Lisa Spielman, PhD

      Affiliations

    • Private Consultant, Congers, NY
    • ,
  • Steve Flanagan, MD

      Affiliations

    • New York University Rusk Institute of Rehabilitation Medicine, New York, NY
    • ,
  • Annika Ginsberg, BA

      Affiliations

    • Cancer Institute, New York University School of Medicine, New York, NY
    • ,
  • Clara Engmann, BA

      Affiliations

    • Department of Rehabilitation Medicine, Mount Sinai School of Medicine, New York, NY
    • ,
  • Matthew Egan, BS

      Affiliations

    • Department of Rehabilitation Medicine, Mount Sinai School of Medicine, New York, NY
    • ,
  • Felicia Ambrose, MD

      Affiliations

    • Department of Rehabilitation Medicine, Mount Sinai School of Medicine, New York, NY
    • ,
  • Brian Greenwald, MD

      Affiliations

    • Department of Rehabilitation Medicine, Mount Sinai School of Medicine, New York, NY

References 

  1. Ashman TA, Spielman LA, Hibbard MR, Silver JM, Chandna T, Gordon WA. Psychiatric challenges in the first 6 years after traumatic brain injury: cross-sequential analyses of Axis I disorders. Arch Phys Med Rehabil. 2004;85:S36–S42
  2. Kim E, Lauterbach EC, Reeve A, et al. Neuropsychiatric complications of traumatic brain injury: a critical review of the literature (a report by the ANPA committee on research). J Neuropsychiatry Clin Neurosci. 2007;19:106–127
  3. Rapoport MJ, McCullagh S, Shammi P, Feinstein A. Cognitive impairment associated with major depression following mild and moderate traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2005;17:61–65
  4. Hibbard MR, Uysal S, Kepler K, Bogdany J, Silver J. Axis I psychopathology in individuals with traumatic brain injury. J Head Trauma Rehabil. 1998;13:24–39
  5. Jorge RE, Robinson RG, Starkstein SE, Arndt SV. Depression and anxiety following traumatic brain injury. J Neuropsychiatry Clin Neurosci. 1993;5:369–374
  6. Jorge RE, Robinson RG, Arndt SV, Starkstein SE, Forrester AW, Geisler F. Depression following traumatic brain injury: a 1 year longitudinal study. J Affect Disord. 1993;27:233–243
  7. Jorge RE, Robinson RG, Arndt S. Are there symptoms that are specific for depressed mood in patients with traumatic brain injury?. J Nerv Ment Dis. 1993;181:91–99
  8. Jorge RE, Robinson RG, Moser D, Tateno A, Crespo-Facorro B, Arndt S. Major depression following traumatic brain injury. Arch Gen Psychiatry. 2004;61:42–50
  9. Fann JR, Katon WJ, Uomoto JM, Esselman PC. Psychiatric disorders and functional disability in outpatients with traumatic brain injuries. Am J Psychiatry. 1995;152:1493–1499
  10. Bowen A, Neumann V, Conner M, Tennant A, Chamberlain MA. Mood disorders following traumatic brain injury: identifying the extent of the problem and the people at risk. Brain Inj. 1998;12:177–190
  11. Holsinger T, Steffens DC, Phillips C, et al. Head injury in early adulthood and the lifetime risk of depression. Arch Gen Psychiatry. 2002;59:17–22
  12. Kreutzer JS, Seel RT, Gourley E. The prevalence and symptom rates of depression after traumatic brain injury: a comprehensive examination. Brain Inj. 2001;15:563–576
  13. Glenn MB, O'Neil-Pirozzi T, Goldstein R, Burke D, Jacob L. Depression amongst outpatients with traumatic brain injury. Brain Inj. 2001;15:811–818
  14. Seel RT, Kreutzer JS, Rosenthal M, Hammond FM, Corrigan JD, Black K. Depression after traumatic brain injury: a national institute on disability and rehabilitation research model systems multicenter investigation. Arch Phys Med Rehabil. 2003;84:177–184
  15. Koponen S, Taiminen T, Portin R, et al. Axis I and II psychiatric disorders after traumatic brain injury: a 30-year follow-up study. Am J Psychiatry. 2002;159:1315–1321
  16. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry. 2005;62:593–602
  17. Bourdon KH, Rae DS, Locke BZ, Narrow WE, Regier DA. Estimating the prevalence of mental disorders in U.S. adults from the epidemiologic catchment area survey. Public Health Rep. 1992;107:663–668
  18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed.. Washington, DC: APA; 1994;
  19. Chamelian L, Feinstein A. The effect of major depression on subjective and objective cognitive deficits in mild to moderate traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2006;18:33–38
  20. Rapoport MJ, McCullagh S, Streiner D, Feinstein A. The clinical significance of major depression following mild traumatic brain injury. Psychosomatics. 2003;44:31–37
  21. Levin HS, McCauley SR, Josic CP, et al. Predicting depression following mild traumatic brain injury. Arch Gen Psychiatry. 2005;62:523–528
  22. Hibbard MR, Ashman TA, Spielman LA, Chun D, Charatz HJ, Melvin S. Relationship between depression and psychosocial functioning after traumatic brain injury. Arch Phys Med Rehabil. 2004;85:S43–S53
  23. Fedoroff JP, Starkstein SE, Forrester AW, et al. Depression in patients with acute traumatic brain injury. Am J Psychiatry. 1992;149:918–923
  24. Deb S, Lyons I, Koutzoukis C, Ali I, McCarthy G. Rate of psychiatric illness 1 year after traumatic brain injury. Am J Psychiatry. 1999;156:374–378
  25. Bryant RA, Marosszeky JE, Crooks J, Baguley I, Gurka J. Coping style and post-traumatic stress disorder following severe traumatic brain injury. Brain Inj. 2000;14:175–180
  26. Jorge RE, Robinson RG, Starkstein SE, Arndt SV. Influence of major depression on 1-year outcome in patients with traumatic brain injury. J Neurosurg. 1994;81:726–733
  27. van Reekum R, Bolago I, Finlayson MA, Garner S, Links PS. Psychiatric disorders after traumatic brain injury. Brain Inj. 1996;10:319–327
  28. Malec JF, Testa JA, Rush BK, Brown AW, Moessner AM. Self-assessment of impairment, impaired self-awareness, and depression after traumatic brain injury. J Head Trauma Rehabil. 2007;22:156–166
  29. Rosenthal M, Christensen BK, Ross TP. Depression following traumatic brain injury. Arch Phys Med Rehabil. 1998;79:90–103
  30. National Institute of Health. Rehabilitation of persons with traumatic brain injury. NIH Consensus Statement. 1998;16:Oct 26-28
  31. Tenovuo O. Pharmacological enhancement of cognitive and behavioral deficits after traumatic brain injury. Curr Opin Neurol. 2006;19:528–533
  32. O'Shanick GJ. Update on antidepressants. J Head Trauma Rehabil. 2006;21:282–284
  33. Zafonte RD, Cullen N, Lexell J. Serotonin agents in the treatment of acquired brain injury. J Head Trauma Rehabil. 2002;17:322–334
  34. Alderfer BS, Arciniegas DB, Silver JM. Treatment of depression following traumatic brain injury. J Head Trauma Rehabil. 2005;20:544–562
  35. Jorge RE, Starkstein SE. Pathophysiologic aspects of major depression following traumatic brain injury. J Head Trauma Rehabil. 2005;20:475–487
  36. Glenn MB, Wroblewski B. Twenty years of pharmacology. J Head Trauma Rehabil. 2005;20:51–61
  37. Silver JM, Sandberg DP, Hales RE. New approaches in the pharmacotherapy of posttraumatic stress disorder. J Clin Psychiatry. 1990;51(Suppl):33–38
  38. Turner-Stokes L, MacWalter R Guideline Development Group of the British Society of Rehabilitation Medicine, British Geriatrics Society, Royal College of Physicians London. Use of antidepressant medication following acquired brain injury: concise guidance. Clin Med. 2005;5:268–274
  39. Warden DL, Gordon B, et al. Neurobehavioral Guidelines Working Group Guidelines for the pharmacologic treatment of neurobehavioral sequelae of traumatic brain injury. J Neurotrauma. 2006;23:1468–1501
  40. Almeida OP, Waterreus A, Hankey GJ. Preventing depression after stroke: results from a randomized placebo-controlled trial. J Clin Psychiatry. 2006;67:1104–1109
  41. Spalletta G, Ripa A, Bria P, Caltagirone C, Robinson RG. Response of emotional unawareness after stroke to antidepressant treatment. Am J Geriatr Psychiatry. 2006;14:220–227
  42. Murray V, von Arbin M, Bartfai A, et al. Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression. J Clin Psychiatry. 2005;66:708–716
  43. Spalletta G, Caltagirone C. Sertraline treatment of post-stroke major depression: an open study in patients with moderate to severe symptoms. Funct Neurol. 2003;18:227–232
  44. Rasmussen A, Lunde M, Poulsen DL, Sorensen K, Qvitzau S, Bech P. A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics. 2003;44:216–221
  45. Spalletta G, Guida G, Caltagirone C. Is left stroke a risk-factor for selective serotonin reuptake inhibitor antidepressant treatment resistance?. J Neurol. 2003;250:449–455
  46. Turner-Stokes L, Hassan N, Pierce K, Clegg F. Managing depression in brain injury rehabilitation: the use of an integrated care pathway and preliminary report of response to sertraline. Clin Rehabil. 2002;16:261–268
  47. Turner-Stokes L, Hassan N. Depression after stroke: a review of the evidence base to inform the development of an integrated care pathway (Part 2: treatment alternatives). Clin Rehabil. 2002;16:248–260
  48. Goodnick PJ, Hernandez M. Treatment of depression in comorbid medical illness. Expert Opin Pharmacother. 2000;1:1367–1384
  49. Burns A, Russell E, Stratton-Powell H, Tyrell P, O'Neill P, Baldwin R. Sertraline in stroke-associated lability of mood. Int J Geriatr Psychiatry. 1999;14:681–685
  50. Piccinelli M, Patterson M, Braithwaite I, Boot D, Wilkinson G. Anxiety and depression disorders 5 years after severe injuries: a prospective follow-up study. J Psychosom Res. 1999;46:455–464
  51. Kamijima K, Aoki M. Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders. Expert Rev Neurother. 2006;6:945–956
  52. Davidson JR. Pharmacologic treatment of acute and chronic stress following trauma: 2006. J Clin Psychiatry. 2006;(67 Suppl 2):34–39
  53. Cipriani A, Brambilla P, Furukawa T, et al. Fluoxetine versus other types of pharmacotherapy for depression. Cochrane Database Syst Rev. 2005;(4):CD004185
  54. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62
  55. Beck AT, Steer R, Brown G. Beck Depression Inventory-II. San Antonio: Psychological Corp; 1996;
  56. Andrews FM, Withey SB. Social indicators of well-being: Americans' perceptions of life quality. New York: Plenum Pr; 1976;
  57. Beck AT. Beck Anxiety Inventory. San Antonio: Psychological Corp; 1993;
  58. Fann JR, Uomoto JM, Katon WJ. Sertaline in the treatment of major depression following mild traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2000;12:226–232
  59. First M, Spitzer R, Gibbon M, Williams J. User's guide for the structured clinical interview for DSM-IV Axis I Disorders - SCID. Washington, DC: American Psychiatric Pr; 1997;
  60. Spitzer RL, Williams JB, Gibbon M, First MB. The structured clinical interview for DSM-III-R (SCID) (I: history, rationale, and description). Arch Gen Psychiatry. 1992;49:624–629
  61. Bowman ES, Coons PM. The differential diagnosis of epilepsy, pseudoseizures, dissociative identity disorder, and dissociative disorder not otherwise specified. Bull Menninger Clin. 2000;64:164–180
  62. Segal DL, Hersen M, Van Hasselt VB. Reliability of the structured clinical interview for DSM-III-R: an evaluative review. Compr Psychiatry. 1994;35:316–327
  63. Fach M, Bischof G, Schmidt C, Rumpf HJ. Prevalence of dependence on prescription drugs and associated mental disorders in a representative sample of general hospital patients. Gen Hosp Psychiatry. 2007;29:257–263
  64. Jones JE, Hermann BP, Woodard JL, et al. Screening for major depression in epilepsy with common self-report depression inventories. Epilepsia. 2005;46:731–735
  65. Booth BM, Kirchner JE, Hamilton G, Harrell R, Smith GR. Diagnosing depression in the medically ill: validity of a lay-administered structured diagnostic interview. J Psychiatr Res. 1998;32:353–360
  66. Williams JB. A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry. 1988;45:742–747
  67. Faries D, Herrera J, Rayamajhi J, DeBrota D, Demitrack M, Potter WZ. The responsiveness of the Hamilton Depression Rating Scale. J Psychiatr Res. 2000;34:3–10
  68. Williams JB, Gibbon M, First MB, et al. The structured clinical interview for DSM-III-R (SCID) (II. Multisite test-retest reliability). Arch Gen Psychiatry. 1992;49:630–636
  69. Maier W. The Hamilton Depression Scale and its alternatives: a comparison of their reliability and validity. Psychopharmacol Ser. 1990;9:64–71
  70. Maier W, Heuser I, Philipp M, Frommberger U, Demuth W. Improving depression severity assessment–II (Content, concurrent and external validity of three observer depression scales). J Psychiatr Res. 1988;22:13–19
  71. Maier W, Philipp M, Heuser I, Schlegel S, Buller R, Wetzel H. Improving depression severity assessment–I (Reliability, internal validity and sensitivity to change of three observer depression scales). J Psychiatr Res. 1988;22:3–12
  72. Rehm LP, O'Hara MW. Item characteristics of the Hamilton Rating Scale for Depression. J Psychiatr Res. 1985;19:31–41
  73. Bech P, Allerup P, Reisby N, Gram LF. Assessment of symptom change from improvement curves on the Hamilton Depression Scale in trials with antidepressants. Psychopharmacology (Berl). 1984;84:276–281
  74. Gibbons RD, Clark DC, Kupfer DJ. Exactly what does the Hamilton Depression Rating Scale measure?. J Psychiatr Res. 1993;27:259–273
  75. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56:893–897
  76. Trahan DE, Ross CE, Trahan SL. Relationships among postconcussional-type symptoms, depression, and anxiety in neurologically normal young adults and victims of mild brain injury. Arch Clin Neuropsychol. 2001;16:435–445
  77. Fleming JM, Strong J, Ashton R. Cluster analysis of self-awareness levels in adults with traumatic brain injury and relationship to outcome. J Head Trauma Rehabil. 1998;13:39–51
  78. Wallace CA, Bogner J. Awareness of deficits: emotional implications for persons with brain injury and their significant others. Brain Inj. 2000;14:549–562
  79. Dijkers M, Layman D, Ashman T, Brown M. Self-report of quality of life by persons with traumatic brain injury: a reliability study. Qual Life Res. 2002;11:672
  80. Diggle PJ, Heagerty P, Liang KY, Zeger SL. Analysis of longitudinal data. 2nd ed.. Oxford: Oxford Univ Pr; 2002;
  81. Robins LN, Regier DA. Psychiatric disorders in America: the epidemiologic catchment area study. New York: Free Pr; 1991;
  82. Demyttenaere K, Bruffaerts R, Posada-Villa J, et al. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization world mental health surveys. JAMA. 2004;291:2581–2590
  83. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the national comorbidity survey replication (NCS-R). JAMA. 2003;289:3095–3105
  84. Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000?. J Clin Psychiatry. 2003;64:1465–1475
  85. Blazer DG, Kessler RC, McGonagle KA, Swartz MS. The prevalence and distribution of major depression in a national community sample: the national comorbidity survey. Am J Psychiatry. 1994;151:979–986
  86. US Department of Health and Human Services. Mental health: culture, race, and ethnicity: a supplement to mental health: a report of the surgeon general-executive summary. In: Rockville: US Dept of Health and Human Services, Public Health Service, Office of the Surgeon General; 2001;
  87. Givens JL, Houston TK, Van Voorhees BW, Ford DE, Cooper LA. Ethnicity and preferences for depression treatment. Gen Hosp Psychiatry. 2007;29:182–191
  88. Wang J, White-Means SI, Hufstader MA, Walker GD. The economic implications of the racial and ethnic disparities in the use of selective serotonin reuptake inhibitors. Curr Med Res Opin. 2007;23:853–863

 Supported by the National Institute of Disability and Rehabilitation Research, United States Department of Education (grant no. H133A020501), and Pfizer Pharmaceutical Company (ClinicalTrials.gov identifier: NCT00233103).

 No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit on the authors or on any organization with which the authors are associated.

PII: S0003-9993(09)00083-5

doi: 10.1016/j.apmr.2008.11.005

Archives of Physical Medicine and Rehabilitation
Volume 90, Issue 5 , Pages 733-740 , May 2009

Article Tools

* Image Usage & Resolution